TITLE

What Is Controlled for in Placebo-Controlled Trials?

AUTHOR(S)
Fillingim, Roger B.; Price, Donald D.
PUB. DATE
September 2005
SOURCE
Mayo Clinic Proceedings;Sep2005, Vol. 80 Issue 9, p1119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the importance of placebo effects in pain treatment and research. Approach in evaluating the influence of placebo in treatments; Analysis of factors that contribute to the magnitude of placebo analgesia an experimental paradigm; Neurobiology of placebo analgesia.
ACCESSION #
18184279

 

Related Articles

  • A Review of Recent Clinical Experience with Almotriptan. Diener, Hans-Christoph // Drugs;2006 Supplement, Vol. 66, p17 

    The purpose of this paper is to review six recently completed trials (three double-blind, three open-label) providing valuable data on efficacy and tolerability of almotriptan in 'real world' settings. In a randomized double-blind trial, almotriptan 12.5 mg and zolmitriptan 2.5 mg achieved...

  • Homotoxicology—a review of randomised clinical trials. Ernst, E.; Schmidt, K. // European Journal of Clinical Pharmacology;Jul2004, Vol. 60 Issue 5, p299 

    Aim. Homotoxicology is a form of therapy that uses homoeopathically diluted remedies with a view of eliminating toxins from the body. It is not a therapeutic method based on accepted scientific principles or biological plausibility. Yet numerous clinical studies have claimed efficacy. The aim of...

  • Ethics and Justice. Hindin, Toby Jane // Applied Clinical Trials;Aug2004, Vol. 13 Issue 8, p12 

    Comments on the issue of placebo-controlled trials as the standard for evaluating new treatment. Concerns over ethics and justice as the nature of drug therapy changes due to the development of new biologic and biogenetic therapies.

  • Pregabalin in Postherpetic Neuralgia: A Viewpoint by Robert W. Johnson. Johnson, Robert W. // Drugs;2005, Vol. 65 Issue 1, p119 

    This article focuses on a study related to pregabalin in postherpetic neuralgia (PHN). Gabapentin has deservedly become a standard, if relatively expensive, therapy for PHN. Pregabalin is assumed to have a similar mode of action compared with gabapentin, but may have characteristics that make...

  • The effect of Neuragen PN® on Neuropathic pain: A randomized, double blind, placebo controlled clinical trial. Li, Li // BMC Complementary & Alternative Medicine;2010, Vol. 10, p22 

    Background: A double blind, randomized, placebo controlled study to evaluate the safety and efficacy of the naturally derived topical oil, "Neuragen PN®" for the treatment of neuropathic pain. Methods: Sixty participants with plantar cutaneous (foot sole) pain due to all cause peripheral...

  • Paliperidone Extended Release. Yang, Lily P.H.; Plosker, Greg L. // CNS Drugs;2007, Vol. 21 Issue 5, p417 

    â–´ Paliperidone extended release (ER) is an atypical antipsychotic that is administered orally once daily to provide consistent plasma drug concentrations over 24 hours in adult patients with schizophrenia. â–´ In four well controlled trials, once-daily administration of paliperidone ER...

  • Randomized, Placebo-Controlled Evaluation of Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal. Caballero, Miguel; Navarrete, Pilar; Prades, Eduard; Domenech, Juan; Bemal-Sprekelsen, Manuel // Annals of Otology, Rhinology & Laryngology;Aug2009, Vol. 118 Issue 8, p552 

    Objectives: We evaluated the efficacy over a short period of time of two ceruminolytic products, Otocerum (chlorobutanol, phenol, turpentine essence, ethyl alcohol; Reig Jofre Laboratories, Barcelona, Spain) and Taponoto (potassium carbonate, ethyl alcohol, glycerol, thymol; Teofarma Iberica SA,...

  • How many good antidepressant medications have we missed? Blier, Pierre // Journal of Psychiatry & Neuroscience;Jul2004, Vol. 29 Issue 4, p248 

    This article focuses on antidepressant medications. Once antidepressant medications have been demonstrated to be safe for human use, they generally have to prove superior to placebo in at least 2 randomized, double-blind, placebo-controlled studies to be approved by regulatory agencies. It is...

  • Static magnets for reducing pain: systematic review and meta-analysis of randomized trials. Pittler, Max H.; Brown, Elizabeth M.; Ernst, Edzard // CMAJ: Canadian Medical Association Journal;9/25/2007, Vol. 177 Issue 7, p736 

    Background: Static magnets are marketed with claims of effectiveness for reducing pain, although evidence of scientific principles or biological mechanisms to support such claims is limited. We performed a systematic review and meta-analysis to assess the clinical evidence from randomized trials...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics